Stefano Bellosta (S Bellosta)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Vascular Smooth Muscle Cells

Tyrosine Kinase

Monoclonal Antibody

Top Venues

Cardiovascular drugs and therapy

Expert opinion on drug metabolism & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Stefano Bellosta, Alberto Corsini
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs. Expert opinion on drug metabolism & toxicology (2024)
Daniela Grejtakova, Iveta Boronova, Jarmila Bernasovska, Stefano Bellosta
PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes. Cardiovascular drugs and therapy (2024)
Laura Bianchi, Isabella Damiani, Silvia Castiglioni, Alfonso Carleo, Rossana De Salvo, Clara Rossi, Alberto Corsini, Stefano Bellosta
Smooth Muscle Cell Phenotypic Switch Induced by Traditional Cigarette Smoke Condensate: A Holistic Overview. International journal of molecular sciences 24 (7) (2023)
Clara Rossi, Marco Venturin, Jakub Gubala, Angelisa Frasca, Alberto Corsini, Cristina Battaglia, Stefano Bellosta
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence. Biomedicines 11 (12) (2023)
Arianna Consiglio, Marco Venturin, Sabrina Briguglio, Clara Rossi, Giorgio Grillo, Stefano Bellosta, Maria Grazia Cattaneo, Vito Flavio Licciulli, Cristina Battaglia
Lost in HELLS: Disentangling the mystery of SALNR existence in senescence cellular models. PloS one 18 (5) (2023)
Clara Rossi, Marco Venturin, Jakub Gubala, Angelisa Frasca, Alberto Corsini, Cristina Battaglia, Stefano Bellosta
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence. Biomedicines 11 (12) (2023)
Stefano Bellosta, Clara Rossi, A S Alieva, Alberico Luigi Catapano, A Corsini, Andrea Baragetti
Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review. Cardiovascular drugs and therapy (2022)
Stefano Bellosta, Francesca Selmin, Giulia Magri, Silvia Castiglioni, Patrizia Procacci, Patrizia Sartori, Edoardo Scarpa, Valerio Tolva, Clara Rossi, Francesco Puoci, Loris Rizzello, Francesco Cilurzo
Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia. Molecular pharmaceutics 19 (11) (2022)
Isabella Damiani, Silvia Castiglioni, Alicja Sochaj-Gregorczyk, Fabrizia Bonacina, Irma Colombo, Valentina Rusconi, Jacek Otlewski, Alberto Corsini, Stefano Bellosta
Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells. Biology 10 (8) (2021)
Leonardo Sandrini, Laura Castiglioni, Patrizia Amadio, José Pablo Werba, Sonia Eligini, Susanna Fiorelli, Marta Zarà, Silvia Castiglioni, Stefano Bellosta, Francis S Lee, Luigi Sironi, Elena Tremoli, Silvia Stella Barbieri
Impact of BDNF Val66Met Polymorphism on Myocardial Infarction: Exploring the Macrophage Phenotype. Cells 9 (5) (2020)
Besa Emini Veseli, Paola Perrotta, Pieter Van Wielendaele, Anne-Marie Lambeir, Anahita Abdali, Stefano Bellosta, Giovanni Monaco, Geert Bultynck, Wim Martinet, Guido R Y De Meyer
Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3). FEBS letters 594 (18) (2020)
Isabella Damiani, Alberto Corsini, Stefano Bellosta
Potential statin drug interactions in elderly patients: a review. Expert opinion on drug metabolism & toxicology 16 (12) (2020)
Stefano Bellosta, Alberto Corsini
Statin drug interactions and related adverse reactions: an update. Expert opinion on drug safety 17 (1) (2017)